.svg){kind=logo}
.svg){kind=logo}
.svg){kind=logo}
Who We Are
TheroGenX is a privately held company that is creating a fully-integrated, leading-edge network that provides a more holistic approach to healthcare. TheroGenX is committed to developing, acquiring or partnering with companies that deliver innovative, safe and effective healthcare technology.
We recruit and retain disrupters, thought-leaders, people that want to advance healthcare and research and validate that there are non-toxic solutions to problems that plague people’s everyday quality of life.
Forging a new path in healthcare is not easy. At TheroGenX, we believe the time is now. The time to create new options for longstanding medical ailments. It is time to educate healthcare providers and patients about TheroGenX’s healthcare solutions:
Diagnostics
The TheroGenX Diagnostics Advantage: Complete, Accurate, Rapid, Reliable
Sequence-based solutions: TheroGenX's Nanopore Technology identifies the most common pathogenic microbes, limiting the confusion of competitive NGS technology that does not separate non-harmful microbiome flora. More than 290 fungi, bacteria and eukaryotic organisms, representing 98% of known pathogens, are identified and reported to the provider. Closely related organisms and gene resistant cassettes found in sample pathogens are uniquely identified. The TheroGenX DX report is delivered to the provider in approximately 72 hours, complete with appropriate pharmacologic treatment recommendations, based on tissue type and resistance gene identified.
Medical
TheroGenX Medical is developing a variety of specialty orthopedic surgery implants and tools. The company is submitting several products for FDA approval and is excited to launch innovative solutions that address market needs.
Bio
At TherogenX, we specialize in advanced biologic processing and structural extracellular matrix (ECM) technologies, supported by a team with decades of experience across medical, scientific, and manufacturing disciplines. Our focus is on developing consistent, high-quality biologic systems designed to support tissue environments across surgical and clinical applications.
All TherogenX products are processed and handled in accordance with applicable FDA regulations and industry standards, including cGMP, cGTP, and cGLP guidelines. We implement rigorous quality control measures, including comprehensive pre- and post-processing testing protocols, to support product safety, consistency, and performance.
Our platform is built around extracellular matrix-based technologies that provide structural support, protective barrier function, and tissue separation. These systems are designed to integrate seamlessly into clinical workflows while maintaining the inherent structural characteristics of the source material.
We utilize a controlled and standardized processing approach that preserves key physical and architectural properties of the tissue matrix, including collagen and hyaluronic acid components. This enables us to deliver products with consistent handling characteristics and reliable performance across a wide range of applications.
TherogenX operates within a vertically integrated model, allowing for full oversight of sourcing, processing, testing, and manufacturing. This approach supports scalability, reproducibility, and long-term platform growth while maintaining a strong commitment to quality and compliance.
Our mission is to provide clinicians, partners, and healthcare organizations with dependable, structurally focused biologic solutions that support modern clinical needs through innovation, precision, and consistency.
